Halozyme Appoints Bernadette Connaughton To Board Of Directors

SAN DIEGO, Sept. 10, 2018 -- (Healthcare Sales & Marketing Network) -- Halozyme Therapeutics, Inc. (NASDAQ : HALO ), a biotechnology company developing novel oncology and drug-delivery therapies, today announced the appointment of Bernadette Connaughton t... Biopharmaceuticals, Oncology, Personnel Halozyme Therapeutics, pegvorhyaluronidase
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news